Olivia Pabois1, Robert M Ziolek2, Christian D Lorenz3, Sylvain Prévost4, Najet Mahmoudi5, Maximilian W A Skoda6, Rebecca J L Welbourn7, Margarita Valero8, Richard D Harvey9, Myriam M-L Grundy10, Peter J Wilde11, Isabelle Grillo12, Yuri Gerelli13, Cécile A Dreiss14. 1. Institut Laue-Langevin, Grenoble 38000, France; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, United Kingdom. Electronic address: olivia.pabois@kcl.ac.uk. 2. Department of Physics, King's College London, London WC2R 2LS, United Kingdom. Electronic address: rob.ziolek@kcl.ac.uk. 3. Department of Physics, King's College London, London WC2R 2LS, United Kingdom. Electronic address: chris.lorenz@kcl.ac.uk. 4. Institut Laue-Langevin, Grenoble 38000, France. Electronic address: prevost@ill.fr. 5. ISIS Neutron & Muon Source, STFC Rutherford Appleton Laboratory, Didcot OX11 0QX, United Kingdom. Electronic address: najet.mahmoudi@stfc.ac.uk. 6. ISIS Neutron & Muon Source, STFC Rutherford Appleton Laboratory, Didcot OX11 0QX, United Kingdom. Electronic address: maximilian.skoda@stfc.ac.uk. 7. ISIS Neutron & Muon Source, STFC Rutherford Appleton Laboratory, Didcot OX11 0QX, United Kingdom. Electronic address: becky.welbourn@stfc.ac.uk. 8. Department of Physical Chemistry, University of Salamanca, Salamanca 37007, Spain. Electronic address: mvalero@usal.es. 9. Department of Pharmaceutical Chemistry, University of Vienna, Vienna A-1090, Austria. Electronic address: richard.harvey@univie.ac.at. 10. PEGASE, INRAE, Institut Agro, Saint Gilles 35590, France. Electronic address: myriam.grundy@inrae.fr. 11. Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, United Kingdom. Electronic address: peter.wilde@quadram.ac.uk. 12. Institut Laue-Langevin, Grenoble 38000, France. 13. Institut Laue-Langevin, Grenoble 38000, France; Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy. Electronic address: y.gerelli@univpm.it. 14. Institute of Pharmaceutical Science, King's College London, London SE1 9NH, United Kingdom. Electronic address: cecile.dreiss@kcl.ac.uk.
Abstract
HYPOTHESES: Bile salts (BS) are biosurfactants released into the small intestine, which play key and contrasting roles in lipid digestion: they adsorb at interfaces and promote the adsorption of digestive enzymes onto fat droplets, while they also remove lipolysis products from that interface, solubilising them into mixed micelles. Small architectural variations on their chemical structure, specifically their bile acid moiety, are hypothesised to underlie these conflicting functionalities, which should be reflected in different aggregation and solubilisation behaviour. EXPERIMENTS: The micellisation of two BS, sodium taurocholate (NaTC) and sodium taurodeoxycholate (NaTDC), which differ by one hydroxyl group on the bile acid moiety, was assessed by pyrene fluorescence spectroscopy, and the morphology of aggregates formed in the absence and presence of fatty acids (FA) and monoacylglycerols (MAG) - typical lipolysis products - was resolved by small-angle X-ray/neutron scattering (SAXS, SANS) and molecular dynamics simulations. The solubilisation by BS of triacylglycerol-incorporating liposomes - mimicking ingested lipids - was studied by neutron reflectometry and SANS. FINDINGS: Our results demonstrate that BS micelles exhibit an ellipsoidal shape. NaTDC displays a lower critical micellar concentration and forms larger and more spherical aggregates than NaTC. Similar observations were made for BS micelles mixed with FA and MAG. Structural studies with liposomes show that the addition of BS induces their solubilisation into mixed micelles, with NaTDC displaying a higher solubilising capacity.
HYPOTHESES: Bile salts (BS) are biosurfactants released into the small intestine, which play key and contrasting roles in lipid digestion: they adsorb at interfaces and promote the adsorption of digestive enzymes onto fat droplets, while they also remove lipolysis products from that interface, solubilising them into mixed micelles. Small architectural variations on their chemical structure, specifically their bile acid moiety, are hypothesised to underlie these conflicting functionalities, which should be reflected in different aggregation and solubilisation behaviour. EXPERIMENTS: The micellisation of two BS, sodium taurocholate (NaTC) and sodium taurodeoxycholate (NaTDC), which differ by one hydroxyl group on the bile acid moiety, was assessed by pyrene fluorescence spectroscopy, and the morphology of aggregates formed in the absence and presence of fatty acids (FA) and monoacylglycerols (MAG) - typical lipolysis products - was resolved by small-angle X-ray/neutron scattering (SAXS, SANS) and molecular dynamics simulations. The solubilisation by BS of triacylglycerol-incorporating liposomes - mimicking ingested lipids - was studied by neutron reflectometry and SANS. FINDINGS: Our results demonstrate that BS micelles exhibit an ellipsoidal shape. NaTDC displays a lower critical micellar concentration and forms larger and more spherical aggregates than NaTC. Similar observations were made for BS micelles mixed with FA and MAG. Structural studies with liposomes show that the addition of BS induces their solubilisation into mixed micelles, with NaTDC displaying a higher solubilising capacity.
Authors: Igor Kevin Mkam Tsengam; Marzhana Omarova; Elizabeth G Kelley; Alon McCormick; Geoffrey D Bothun; Srinivasa R Raghavan; Vijay T John Journal: J Phys Chem B Date: 2022-03-14 Impact factor: 2.991
Authors: Nafia F Khan; Malinda Salim; Syaza Y Binte Abu Bakar; Kurt Ristroph; Robert K Prud'homme; Adrian Hawley; Ben J Boyd; Andrew J Clulow Journal: Int J Pharm X Date: 2022-02-09